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ABSTRACT
Objective Stomach cancer is a leading cause of cancer
death, especially in developing countries. Incidence has
been associated with poverty and is also reported to
disproportionately affect indigenous peoples, many of
whom live in poor socioeconomic circumstances and
experience lower standards of health. In this
comprehensive assessment, we explore the burden of
stomach cancer among indigenous peoples globally.
Design The literature was searched systematically for
studies on stomach cancer incidence, mortality and
survival in indigenous populations, including Indigenous
Australians, Maori in New Zealand, indigenous peoples
from the circumpolar region, native Americans and
Alaska natives in the USA, and the Mapuche peoples in
Chile. Data from the New Zealand Health Information
Service and the Surveillance Epidemiology and End
Results (SEER) Program were used to estimate trends in
incidence.
Results Elevated rates of stomach cancer incidence and
mortality were found in almost all indigenous peoples
relative to corresponding non-indigenous populations in
the same regions or countries. This was particularly
evident among Inuit residing in the circumpolar region
(standardised incidence ratios (SIR) males: 3.9, females:
3.6) and in Maori (SIR males: 2.2, females: 3.2).
Increasing trends in incidence were found for some
groups.
Conclusions We found a higher burden of stomach
cancer in indigenous populations globally, and rising
incidence in some indigenous groups, in stark contrast to
the decreasing global trends. This is of major public
health concern requiring close surveillance and further
research of potential risk factors. Given evidence that
improving nutrition and housing sanitation, and
Helicobacter pylori eradication programmes could reduce
stomach cancer rates, policies which address these
initiatives could reduce inequalities in stomach cancer
burden for indigenous peoples.
INTRODUCTION
Globally, stomach cancer incidence has declined
over the past 4–5 decades, but still remains a major
public health problem.1 Stomach cancer is the
second leading cause of cancer death worldwide,
with large geographical differences in incidence and
mortality in different regions and countries.2 In
2008, about three-quarters of cases and deaths from
stomach cancer occurred in low- and middle-income
Significance of this study
What is already known on this subject?
▸ Stomach cancer is the second leading cause of
cancer death worldwide and wide geographical
and ethnic variations exist in its occurrence.
▸ Indigenous peoples carry a disproportionate
burden of stomach cancer; however the extent
of inequalities has not yet been quantified from
a global perspective.
▸ Indigenous peoples often live in poor
socioeconomic circumstances which has
implications for their health and well-being,
including a reduced access to healthcare, which
may increase their risk for certain cancers.
What are the new findings?
▸ Stomach cancer risk in indigenous populations
substantively exceeds that of their
non-indigenous counterparts in a number of
countries with incidence and mortality up to
fivefold that of non-indigenous populations.
▸ By contrast with the well-established declining
trends seen in most countries and regions of
the world, stomach cancer incidence appears to
be increasing in several indigenous groups.
How might it impact on clinical practice in
the foreseeable future?
▸ Due to their socioeconomic circumstances and
dietary habits, indigenous peoples are often at
higher risk for dyspeptic disorders, in particular,
stomach cancer. Increasing awareness among
clinicians may help to gain control of this
global public health problem.
▸ Future prevention and public health measures
must support government policies that focus on
the improvement of social conditions, for
example, housing and reducing overcrowding,
and need to be tailored to specific indigenous
groups.
▸ Further research is required, including
randomised trials, to assess the benefit of
Helicobacter pylori eradication on stomach
cancer risk in indigenous populations. In the
interim, tailored guidelines for eradication in
high-risk groups, especially in children, should
be developed.
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and middle-income countries (LMIC). Rates are also elevated in
Eastern Europe including Russia, as well as certain parts of Latin
America and East Asia.3
Approximately 90% of stomach cancers are adenocarcinomas
which are further divided histologically into two categories:
intestinal and diffuse.4 Both types are strongly associated with
Helicobacter pylori infection,5 the former more common in
older patients and males and linked to dietary factors, smoking
and obesity.1 6 7 The decrease in incidence over the past 40 years
has occurred primarily for the intestinal type, while incidence of
diffuse-type gastric cancer has remained relatively unchanged,
although time trend studies in the USA report increasing rates.8
Furthermore, risk factors for cancers arising in the cardia (prox-
imal) and the non-cardia (distal) parts of the stomach differ.
Whereas cardia stomach cancers, alongside adenocarcinomas of
the oesophagus,9 have been associated with obesity and gastro-
oesophageal reflux as main risk factors, non-cardia tumours are
more common in less developed countries and positively asso-
ciated with lower socioeconomic status and H pylori infection.10
While public health measures, including improved sanitation,
and a greater availability of fresh food have likely contributed to
the steady decline of stomach cancer incidence,11 the resulting
benefits have not necessarily been transferred equitably to all
people. Poverty-associated risk factors, such as housing density
and overcrowding, remain major contributors to the dispropor-
tionate burden of stomach cancer seen in the most deprived popu-
lation groups.12 A particularly high stomach cancer burden has
previously been reported among some indigenous populationsi
13 14 who are also typically over-represented in the lowest socio-
economic groupings in their respective countries.15 16 Although
the political, social and cultural circumstances of indigenous popu-
lations are diverse and unique, historical disadvantage has contin-
ued through the process of colonisation contributing to strikingly
similar patterns of poor current-day health status in many indigen-
ous groups.17 Compared to their non-indigenous counterparts,
indigenous peoples not only experience an increased burden of
lifestyle diseases, such as obesity, type 2 diabetes, cardiovascular
disease and mental disorders, but also retain a high prevalence of
infectious diseases.15 Additionally, higher rates of these comorbid
conditions, together with decreased access to treatment, have
important implications for cancer outcomes, including reduced
survival prospects and elevated mortality rates.15
The extent to which global inequalities of stomach cancer
among indigenous peoples exist has not been systematically
explored. As there is considerable heterogeneity among indigen-
ous peoples worldwide, each group needs individual study in
the context of their political and social histories, environmental
factors and other health determinants in order to derive tailored
public health measures. The aim of this review is to assess avail-
able evidence on the stomach cancer burden in indigenous
peoples worldwide, identifying populations at increased risk of
developing and dying from this cancer and highlighting trends
that deserve closer attention by public health and cancer preven-
tion specialists.
METHODS
We systematically searched the literature up to May 2013 using
PubMed and regional databases (see online supplementary
appendix 1). The search terms and strategy, following the
PRISMA guidelines, can be found in online supplementary
appendix 1. Briefly, separate searches were carried out using a
predefined set of population terms, complemented with geo-
graphical restrictions and epidemiological terms, with a focus
on stomach cancer. Studies were included if age-standardised
rates or rate ratios (incidence and/or mortality) or survival pro-
portions in indigenous peoples (relative to non-indigenous)
were reported. First, titles and abstracts were reviewed in order
to identify potentially relevant studies. Subsequently, a manual
search was carried out based on the references cited in the rele-
vant papers. Case reports, reviews and editorials were excluded.
Studies were grouped and reviewed based on geographical
regions and ethnic/indigenous groups: circumpolar region
(including Inuit, Alaska Natives, Greenlanders, Sami, Indigenous
Siberians and others), USA (American Indians and Alaska
Natives), South America (among others, Mapuche), Australia
(Indigenous Australians) and New Zealand (Maori). Studies
with results displayed in figures only were excluded; studies
with less than 10 cases were included in online supplementary
table S1, but were not considered in the results and the conclu-
sion. If there was clear overlap between studies, only the most
comprehensive or most recent study was included.
To complement the literature search, we analysed trends in
incidence in two indigenous groups, with data from routine
sources in New Zealand and the USA. Specifically, data on new
cases of stomach cancer among Maori and non-Maori were
available from annual reports of the New Zealand Ministry of
Health18 and among American Indians and Alaska Natives
(AI/AN) from the Surveillance, Epidemiology and End Results
(SEER) Program (13 registries) for the period 1995–2009.19
We calculated 3-year averaged age-standardised incidence
rates using the world standard population and the estimated
annual percentage change (EAPC) using joinpoint regression
analysis,20 a common method in cancer epidemiology to analyse
incidence and mortality trends.. Using this method, abrupt
changes in long-term trends, linear segments of time during
which rates are relatively stable, can be identified and tested.
EAPCs were calculated by fitting connected linear trends on a
log scale with calendar year as a regressor variable, assuming
constant variance and uncorrelated errors, allowing for up to
two joinpoints (three trend-line segments). The final model pro-
vides an estimate of the direction and magnitude of the trend
between each set of joinpoints, thus avoiding the need to base
trend estimation on arbitrary calendar periods. STATAV.11 and
Joinpoint 4.0 were used for the statistical analyses.
RESULTS
Literature search
The search yielded 5219 studies, 74 of which were relevant for
our overview (see online supplementary figure S1). Five main
regions and their indigenous peoples were identified based on
the results of our search: Indigenous Australians, Maori in New
Zealand, indigenous peoples from the circumpolar region
(including Inuit, Sami and Indigenous Siberians), Native
Americans and Alaska Natives in the USA and Mapuche peoples
in Chile.
Incidence
Totally, 57 studies exploring cancer incidence were included (see
Methods). Stomach cancer incidence among all indigenous
groups exceeded that of their non-indigenous counterparts (see
online supplementary table S1). The highest rates of stomach
cancer were observed in Indigenous Siberians,21 22 Mapuche23
iFor clarification and consistency, initial capitals for the term indigenous
were only used if they referred to a (recognised) population group, such
as Indigenous Australians, but not when they were used as an adjective
to refer to indigenous peoples in general.
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and among Alaskan Inuit.24 Incidence rates in men were double
those of women in most populations examined (figures 1–3).
Trends in incidence
Age-standardised incidence rates rose in male indigenous
Greenlanders from 5.9 for the period 1955–196425 to 23.4 in
1989–200324 and similarly among Alaska Natives.26 Whereas
Paltoo and colleagues27 found an increasing trend in Native
Americans and Alaska Natives between 1992 and 1999 — non-
significant in men (EAPC: +3.3%) and significant in women
(+11%) — Espey and colleagues28 found significant decreases
during 1975–1988 (−1.2%) and 1988–2004 (−2.1%).
Declining stomach cancer incidence rates after 1988 were
observed in American Indians and Alaska Natives based on
SEER data,19 with a significant annual decline of 8.4% among
women between 1998 and 2004, and in men of 11.6% per year
Figure 1 Global map of female stomach cancer incidence: comparisons of age-standardised incidence rates (ASIR per 100 000) in indigenous
populations (years of incidence provided) versus national estimates from GLOBOCAN (2008).
Figure 2 Global map of male stomach cancer incidence: comparisons of age-standardised incidence rates (ASIR per 100 000) in indigenous
populations (years of incidence provided) versus national estimates from GLOBOCAN (2008).
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between 2005 and 2008 (figure 4, table 1). The incidence in
Maori men decreased significantly between 1963 and 1984 by
−0.8% per year,29 and more rapidly since 1996 (figure 4,
table 1). However, a significant increase in incidence was
observed in Maori of both sexes since 2000, in contrast with
incidence rates in the non-Maori population which continued to
uniformly decline (figure 4, table 1).
Incidence ratios
A number of studies have compared stomach cancer in indigen-
ous groups with non-indigenous populations using either
standardised incidence ratios (SIR) or incidence rate ratios as
measures of relative risk (RR) (see online supplementary
table S2a). Circumpolar Inuit were at a threefold higher risk of
developing stomach cancer compared with SEER whites,24
similar to Maori in New Zealand when compared to
non-Maori.29 By contrast with increased SIRs among Mapuche
in Chile,23 lower risks for stomach cancer were found among
the indigenous population relative to the non-indigenous popu-
lation of the Amazon basin of Ecuador.30 Notably, SIRs were
higher in women than men in Maori,29 Mapuche,23
AI/ANs28 31 and Sami.32
Subsites
A significantly higher percentage of diffuse-type gastric cancer,
and a higher incidence rate of non-cardia, distal tumours (non-
cardia: 9.7/7.9 per 100 000 in men/women vs cardia: 0.9/0.6)
have been reported in Maori.33 Low rates of cardia adenocarcin-
omas were also noted in American Indians and Alaska Natives
(0.9 per 100 000 in men, 0.2 in women), especially relative to
non-indigenous Caucasians (3.4 in males, 0.9 in females) and
other ethnic groups in the USA.34 High rates of non-cardia were
also observed in Native Americans in the study by Brown and
colleagues.35 In Alaska, the incidence of central/distal stomach
cancer was significantly higher in American Indians and Alaska
Natives relative to non-Hispanic whites (RR men: 5.8, 95% CI
2.6 to 13.5; RR women: 14.9, 95% CI 6.0 to 44.9).31
Mortality
In total, 30 studies examined stomach cancer mortality among
indigenous peoples (see Methods). For Maori, Dockerty et al29
reported high mortality rates from stomach cancer in men (31.4
per 100 000) and women (18.9) between 1950 and 1986, with
annual declines of −0.9% and −1.3%, respectively. Skegg et al36
observed slightly lower mortality rates among Maori 1996–
1997 and more recently, rates decreased to 13.8 in men and 9.6
Figure 4 Trends in age-standardised* incidence rates (ASIR per
100 000) of stomach cancer (smoothed using 3-year moving averages)
in Maori and American Indians/Alaska Natives (AI/AN) 1996–2008 by
sex, with comparisons with non-Maori and the US Caucasian
population, (source: SEER, NZHIS).
Figure 3 Age-standardised incidence rates (ASIR per 100 000) of stomach cancer in indigenous populations (based on literature review) by sex,
with comparisons with more and less developed regions and the world (GLOBOCAN 2008).
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in women in 2009, compared with 4.7 and 1.7 in non-Maori
men and women, respectively.37 Similarly, rates among AI/ANs
were higher than among other ethnic groups, reported as 9.8 in
men and 4.6 in women during 2002–2006.38 Declines in mor-
tality were also found among AI/ANs between 1975 and 1987
(−2.3% per annum), and between 1991 and 2004 (−3.5%).
Similar (but non-significant) trends were observed among
Indigenous Australians between 1977 and 2000 (EAPC:
−0.8%).39 Mortality rates in Indigenous Australians of 21.2 and
7.9 were estimated in men and women, respectively, in a recent
study by Morrell et al.40
Mortality ratios
A high standardised mortality ratio was estimated for stomach
cancer mortality among Indigenous Australian men (2.1; 95%
CI 1.5 to 2.9) and women (2.0; 1.2 to 3.2),41 and among
AI/ANs men (1.47) and women (1.77)42 (see online supplemen-
tary table S2b). By contrast, significantly lower risks were found
in Ontario First Nation men.43 The risk of dying after stomach
cancer was 10 times higher in Alaska Native men relative to US
Caucasians 1994–2008,44 while higher stomach cancer mortal-
ity was reported among Skolt Sami in Finland compared with
both the overall Finnish population as well as other Sami
groups.45
Survival
Six studies reported survival from stomach cancer among indi-
genous peoples. Low relative survival proportions were found
among Mapuche in Chile with 5 years survival only 4.4%
(11.9% in other Hispanics).23 Similarly, Young et al46 observed
the lowest 5 years survival proportions among American Indians
(11% in men and 7% in women) when compared with other
ethnic groups. In a study among American Indians in New
Mexico and Arizona, survival differences could be explained by
stage at diagnosis and treatment.47 Relative survival in American
Indians climbed to 14% between 1983 and 1994,48 however,
cause-specific survival remained lowest of all ethnic groups in
the USA more recently.49 Jeffreys et al50 found slightly lower
age-standardised and stage-standardised relative survival propor-
tions among Maori (15%) relative to non-Maori (22%).
DISCUSSION
Marked contrasts exist in the relative burden of stomach cancer
in indigenous and non-indigenous populations included in this
review, particularly among Inuit in the circumpolar region and
Maori in New Zealand. Whereas incidence and mortality rates
from stomach cancer have uniformly decreased in the last four
decades in most parts of the world,51 rates have increased for
some indigenous population groups. Incidence of stomach
cancer has been associated with poor nutrition and sanitation,52
hallmarks of poverty, and it is plausible that indigenous peoples,
who are among the poorest globally,53 are affected more than
other population groups. A high intake of salt may also play a
key role in modifying risk in some indigenous groups, especially
in the Arctic region where salt is especially prevalent in trad-
itional foods.54 Evidence from migrant studies has shown that
first-generation migrants from countries with high incidence of
stomach cancer that migrate to low-incidence countries largely
retain the risk profile of their country of origin. However,
decreases in the incidence rate have been observed over time
and in successive generations, acknowledging the strong link
between stomach cancer and environmental risk factors, acting
early in life.55 56
H pylori infection can damage the gastrointestinal tract and is
the most consistent risk factor for non-cardia gastric cancer,
accounting for an estimated 75% of all distal gastric cancers
according to a review of global data published in 2008.52
However, only a minority of infected persons develop clinical
signs of infection. Lifetime risks of the acquisition of peptic
ulcers or distal stomach cancer in H pylori-positive persons is
estimated to be 10–15% and 1–2%, respectively.57 H pylori
infection is usually acquired in childhood and is fostered by
overcrowding and poverty.10 In LMICs, the prevalence of
stomach cancer has been found to be similar to that of H pylori
infection, resulting in a much higher burden.58 Studies on the
prevalence of H pylori infection among indigenous peoples
confirm this pattern, suggesting high rates among Maori,59
Indigenous Australians,60 as well as Arctic aboriginal popula-
tions.61 The fact that the relationship between H pylori infec-
tion and stomach cancer is confined to non-cardia (distal)
tumours, was confirmed in some studies that stratified by
Table 1 Estimated annual percentage change (EAPC) in the incidence of stomach cancer and its 95% CIs for Maori and non-Maori and for
American Indians/Alaska Natives (AI/AN) and US Caucasians between 1996 and 2008
Men Women
Year EAPC 95% CI Year EAPC 95% CI
Maori
1996–2000 −10.3 (−16.3 to −3.9) 1996–2000 −11.2 (−15.2 to −6.9)
2000–2008 5.5 (3.0 to 8.1) 2000–2008 5.1 (3.4 to 6.8)
Non-Maori
1996–2008 −1.6 (−2.7 to −0.4) 1996–1999 2.9 (−0.7 to 6.7)
1999–2004 −4.9 (−7.1 to −2.8)
2004–2008 −0.9 (−3.1 to 1.4)
AI/AN
1996–1998 16.2 (−1.9 to 37.6) 1996–1998 17.3 (1.7 to 35.2)
1998–2005 −1.0 (−3.8 to 1.9) 1998–2004 −8.4 (−11.3 to −5.5)
2005–2008 −11.6 (−18.8 to −3.8) 2004–2008 −1.2 (−5.5 to 3.4)
US Caucasians
1996–2002 −2.1 (−2.5 to −1.7) 1996–2008 −0.8 (−1.2 to −0.4)
2002–2008 −1.2 (−1.5 to −0.8)
Bold numbers are significant at p≤0.05 level.
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anatomical subsite, reporting particularly high rates of non-
cardia tumours in indigenous populations.31 62
H pylori infection is curable and comprehensive guidelines
for its management have been developed.63 Elimination therapy
to prevent gastric cancer has been recommended for dyspeptic
persons from high-prevalence regions.64 However, the exact
source of H pylori is still unknown and given that infection is
ubiquitous in many populations (prevalence >80%), elimin-
ation therapy is neither feasible nor (cost-)efficient. Additionally,
elimination rates have decreased in past years due to increasing
bacterial resistance to drug regimens.65 Some studies have also
suggested that H pylori eradication might have detrimental
effects, for example, as a contributing factor to the onset of
Barrett’s oesophagus.66 67 However, this relationship remains
controversial and evidence is needed from clinical trials.
Comprehensive public health approaches to reduce exposure to
H pylori infection may yield more widespread and sustainable
results, including improved housing and living conditions for
indigenous and poor populations who are at increased risk of
developing stomach cancer.
Lifestyle factors, including nutrition and smoking habits, have
both been found to be important in the development of
stomach cancer.10 Maori have one of the highest smoking rates
in the world and also begin smoking at a much earlier age than
many other populations.36 Estimates suggest that up to 17% of
stomach cancer cases may be attributable to smoking,1 with an
increased risk seen in relation to duration and quantity of cigar-
ettes smoked.68 Some studies have found obesity to be asso-
ciated with an increased risk of cardia tumours but a decreased
risk of non-cardia stomach cancer.1 Whereas a high consump-
tion of fresh fruits and vegetables has been found to be protect-
ive, excess salt intake can promote early atrophic gastritis and
gastric cancer.69 The diet of some indigenous peoples is charac-
terised by a higher consumption of salt, for example, salt-cured
whale meat in Alaska, Greenland and Northern Russia,70 and a
lower intake of fresh fruits and vegetables. The traditional Sami
diet, high in red meat and fatty fish and low in vegetables and
fibre, has been reported to contribute to a higher cancer and all-
cause mortality.71 These dietary patterns often reflect cultural
preferences and seasonal availability, as well as economic
circumstances.
The reasons for the observed increase in stomach cancer inci-
dence among indigenous groups included in this review—in
striking contrast to the decreasing trends seen in their non-
indigenous counterparts—are largely unknown. Although, for
example, Inuit tend to have a high seroprevalence of H pylori,
general sociocultural and economic changes point against an
increase in the prevalence of the infection.13 However, trends in
inequalities may also reflect cohort differences in H pylori infec-
tion rates; for example, in New Zealand where a dramatic
demographic shift occurred for the majority of the Maori popu-
lation who moved from rural to city environments beginning in
the late 1940s–1950s.72 Similar to findings from other
studies,1 73 an increased incidence of adenocarcinomas of the
gastric cardia among indigenous people may relate to changes in
lifestyle and higher levels of obesity. In view of the various risk
factors and their possible interactions, it will be important to
distinguish cardia from non-cardia stomach cancers in the future
in order to shed light on the aetiological mechanisms that are
responsible for changes in incidence over time. Additionally, the
subtype of stomach cancer may be contributing to differing out-
comes; for example, compared to non-Maori, Maori appear to
experience more diffuse than intestinal stomach cancer which
has a worse prognosis.62
Stomach cancer has a relatively high case fatality with a
5-year relative survival of 24% in Europe 1995–199974 and
27% in the USA 2002–2008.75 The prospects of early detection
measures, or interventions to reduce potential inequalities in
access to treatment are thus limited, although screening, gene
testing and prophylactic gastrectomy have been offered to fam-
ilies identified with hereditary diffuse gastric cancer since 2000
in New Zealand, and guidelines for management of familial
cancer were recently updated.76–78 Hereditary diffuse stomach
cancer is associated with E-cadherin gene mutations,79 and
while mutations in families predominantly affected by diffuse
gastric cancer have been documented,80 the reasons for the
higher incidence of such sporadic cancers in Maori remains
unclear. The few studies examining stomach cancer mortality or
survival reported lower survival among indigenous Chileans,23
American Indians46–49 and Maori50 81 when compared to their
non-indigenous counterparts. Differentials in both access to,
and quality of, specialised care, as well as more advanced stage
at diagnosis, have been suggested as major determinants of the
survival disadvantage among indigenous groups.
Strengths/Limitations
To our knowledge this is the first assessment of the global
burden of stomach cancer in indigenous populations. However,
different study designs, time periods and population groups,
restricted comparability. This was mainly related to difficulties
in defining and identifying indigenous groups in routine data-
sets. These vary greatly between countries, ranging from purely
geographical indicators (eg, the population of Greenland or res-
iding on Indian reserves), to self-assigned status/ethnicity, includ-
ing that linked to eligibility to access certain health services
dedicated to indigenous groups (eg, the Indian Health Service),
each with potential for ethnic misclassification. This may result
in under-reporting of cancer in indigenous groups, which has
been, for example, known to be substantial in the SEER data-
base.82 It has therefore been proposed to use linkages with
other databases and to include self-identified race in cancer sur-
veillance data in order to improve case ascertainment in Native
Americans and Alaska Natives.83
In many parts of the world, there is no routine collection of
indigenous status in health data. In Latin American countries,
where 10% of the population is indigenous,84 data on cancer in
indigenous peoples is particularly scarce. At present, indigenous
persons are usually assigned based on their self-reported knowl-
edge of an indigenous language, and more encompassing ways
to register indigenous status are still to be developed.30
Under-reporting may also explain the contrasting results from
the two Latin American studies included in this overview.23 30
Additionally, even where data exist, it often remains difficult to
release or gain access to these data due to restrictive policies,
which is a particular issue when attempting to address health
problems in small communities.85
It is important to acknowledge that in New Zealand, changes
in the ethnicity definition used in successive censuses (the
denominator for incidence rate calculations), which include the
time period covered by our analyses, makes the calculation and
comparability of data over time difficult.73 Moreover, recent
work in New Zealand linking census and cancer registry data
suggest Maori cancer registrations have been underestimated by
between 10% and 30% since the 1980s.72 86 Additionally, the
advent of screening and prophylactic gastrectomy in the last
5–7 years may also have contributed to the subsequent increase
in incidence rates for Maori from 2005 onwards.87
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CONCLUSION
The high burden of stomach cancer among indigenous popula-
tions remains a public health concern. The need for careful sur-
veillance and public health action is given added weight by the
observation that stomach cancer incidence is increasing in some
indigenous groups, in contrast with the well-established declin-
ing trends in the disease seen in their non-indigenous counter-
parts within the same regions/countries. Indigenous populations
are heterogeneous with respect to their cultural, political and
historical backgrounds, and differ greatly in terms of health
behaviour and the prevalence and distribution of environmental
risk factors; any assessment of cancer risks and implementation
of prevention strategies must, therefore, reflect such differences.
In the longer term, a clearer understanding of the causes of
the disparate burden of stomach cancer in indigenous popula-
tions is needed, and prevention measures developed accordingly.
Clearly, optimal strategies to prevent stomach cancer on a global
scale must involve improving social conditions, including redu-
cing overcrowding and improving nutrition. In particular,
efforts to further reduce salt intake and promote H pylori eradi-
cation in high-risk indigenous populations could offer a means
to prospectively reduce inequalities in stomach cancer risk and
mortality in the future, but requires further evaluation in rando-
mised clinical trials.
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